111In-RP-782

N/A

Report date: 2025/01/26 15:36:19

Base Information

Drug Name111In-RP-782
Drug Alias Name99mTc-RP-805matrix metalloproteinase inhibitor (Bristol-Myers Squibb)matrix metalloproteinase inhibitor (Lantheus)RP-782-[111In]indium-111-RP-782 +[7] 
ClassificationRadiation-emitting products
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsAortic valve diseasesAtherosclerosisAortic Aneurysm, Abdominal +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesLantheus Holdings Inc
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsAortic valve diseasesAortic Aneurysm, Abdominal
Inactive IndicationsAtherosclerosisMyocardial InfarctionNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A